CIK 0001321834 · Non-accelerated filer<br>Smaller reporting company
Q/C TECHNOLOGIES, INC.
Sign in to watch- Ticker
- QCLS
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 856-848-8698
- Business address
- 1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY, 10036
- Former names
- Q/C TECHNOLOGIES, INC., TNF Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc., Akers Biosciences, Inc., Akers Biosciences Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-01 | Silverman Joshua Executive Chairman | Grant or award | +77,390 | 210,845 | ||
| 2026-07-10 | Silverman Joshua Executive Chairman | Grant or award | +16,620 | 133,455 | ||
| 2026-04-13 | Silverman Joshua Executive Chairman | Grant or award | +16,806 | 116,835 | ||
| 2026-04-13 | Silverman Joshua Executive Chairman | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2026-04-13 | White Billy Joe Director | Grant or award · Employee Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2026-04-13 | Voss Chelsea Sierra Director | Grant or award · Employee Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2026-04-13 | Silverman Joshua Executive Chairman | Grant or award | +162,162 | 262,191 | ||
| 2026-04-13 | Silverman Joshua Executive Chairman | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 50,000 | ||
| 2026-04-13 | Glass Mitchell Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2026-04-13 | Friscia Stephen Director | Grant or award · Employee Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2026-04-13 | Bernstein Bruce Director | Grant or award · Employee Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2026-03-30 | Voss Chelsea Sierra Director | Purchase | +1,753 | $3.15 | $6K | 61,555 |
| 2026-01-16 | Voss Chelsea Sierra Director | Grant or award | +212,500 | 214,900 | ||
| 2026-01-16 | Voss Chelsea Sierra Director | Grant or award | +25,000 | 239,900 | ||
| 2026-01-16 | Voss Chelsea Sierra Director | Grant or award · Employee Stock Option (Right to Buy) | +212,500 | 212,500 | ||
| 2025-11-14 | PharmaCyte Biotech, Inc. 10% owner | Purchase · Warrants | +889,865 | 889,865 | ||
| 2025-11-14 | Glass Mitchell Director, Chief Medical Off. | Grant or award | +11,420 | 12,500 | ||
| 2025-11-14 | White Billy Joe Director | Grant or award | +22,839 | 25,024 | ||
| 2025-11-14 | Silverman Joshua Executive Chairman | Grant or award | +91,356 | 100,029 | ||
| 2025-11-14 | Friscia Stephen Director | Grant or award | +22,839 | 25,000 |
Page 1 of 8 · 142 trades